Archive for June, 2003

Biotech Stock Report – WOW!

Biotech Stock Report – WOW! The market has gotten ahead of itself by chasing stories, but there is, in fact, fundamental improvement in the outlook for the biotech business. Wall Street is anticipating a slough of new products to hit the market in 2003/2004 and biotechs will be rewarded with earnings/profits.



Geron's the Biotech of the Day

Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said it has received a patent that could be used in stem-cell research. The process would be used, if it’s ever needed, to provide an additional level of safety for cell therapies made from human embryonic […]



Geron’s the Biotech of the Day

Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said it has received a patent that could be used in stem-cell research. The process would be used, if it’s ever needed, to provide an additional level of safety for cell therapies made from human embryonic […]



Genentech's Next Move

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to […]



Genentech’s Next Move

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to […]



%d bloggers like this: